Clinical Trial Update: Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing varenicline for cognitive deficits and cigarette smoking in schizophrenia reports efficacy findings and predictors of respons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cigarette Smoking
• Schizophrenia

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Cigarette Smoking | Phase 4 | Status: COMPLETED | Results posted: 2017-12-02